On October 1, 2014 the U.S. Food and Drug Administration finalized guidance on recommendations to manufacturers for managing cybersecurity risks to better protect patient health and information. The purpose of the guidance is to encourage manufacturers to consider possible cybersecurity risks while designing medical devices, and having a plan to manage system or software updates. The FDA believes that this will reduce information security vulnerabilities for interoperable medical devices. (Read more)